Introducing a novel chemotherapeutic drug formulated with anthraflavic acid for treating human breast carcinoma and type 2 diabetes mellitus.

Authors:
Zhao G; Chinnathambi A; Alahmadi TA; Wainwright M.

Journal:
Arch Med Sci

Publication Year: 2021

DOI:
10.5114/aoms/141173

PMCID:
PMC10696992

PMID:
38058699

View on PubMed View on PMC View Publisher
Journal Information

Journal Title: Arch Med Sci

Detailed journal information not available.

Publication Details

Subject Category: Medicine, General & Internal

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"This project was supported by Researchers Supporting Project number RSP-2021/230, King Saud University, Riyadh, Saudi Arabia."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025